Vical, UW Receive Patent For Herpes Simplex Vaccine
The new patent covers DNA vaccines containing the HSV-2 UL49 gene, which encodes the VP22 tegument protein, formulated with or without Vical’s Vaxfectin adjuvant.
Read MorePosted by Clinical Lab Products | Mar 13, 2011 | Infectious Diseases, Sexually Transmitted Diseases |
The new patent covers DNA vaccines containing the HSV-2 UL49 gene, which encodes the VP22 tegument protein, formulated with or without Vical’s Vaxfectin adjuvant.
Read MorePosted by Clinical Lab Products | Mar 13, 2011 | Miscellaneous |
Anthrax had been suspected in deadly 2007 Afghanistan outbreak, but analysis using Abbott’s Ibis T5000 Biosensor came up with the true cause.
Read MorePosted by Clinical Lab Products | Jan 19, 2011 | Cancer, Miscellaneous |
China State Institute of Pharmaceutical Industry to finance 100% of product development in China.
Read MorePosted by Clinical Lab Products | Dec 3, 2010 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits |
Multiplex Lyme, Syphilis, and ToRCH IgG The AtheNA Multi-Lyte® menu offered by Alere Inc, Waltham, Mass, includes three new infectious disease assays. Borrelia VlsE-1/ pepC10 is used as a first-tier test to detect qualitative levels of B. bu
Read MorePosted by Clinical Lab Products | Jul 23, 2010 | Molecular Diagnostics |
MarketResearch.com has announced the addition of Business Insights’ new report “The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine.”
Read More